Literatur

Probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN)

In: BMC Complement. Altern. Med. 10, S. 13.

Weitere Veröffentlichungen:

Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis. A randomised trial.

Weitere Informationen

Probiotic Escherichia coli Nissle 1917 (EcN) for successful remission maintenance of ulcerative colitis in children and adolescents. An open-label pilot study.

Weitere Informationen

Clostridioides difficile-assoziierte Diarrhö – Klinische Studie zur adjuvanten Therapie mit Saccharomyces boulardii

Weitere Informationen

Matthes, H.; Krummenerl, T.; Giensch, M.; Wolff, C.; Schulze, J. (2010): Clinical trial. Probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN).